New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial
Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too
Rituximab Prolonged Survival Of CLL In Phase III Study
A Low-Cost Vaccine To Enter Clinical Trials In A Year
HPV DNA Testing Reduced Cervical Cancer Precursors
Targeting Men At High Risk Finds More Head & Neck Cancer
Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds
Multivitamin Use Doesn’t Impact Outcomes, Study Finds
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- What are you reading in 2023?
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence